HopeStage
Back to overview

ADHD studies

Topics
More filters

ADHD

Attention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.

1811studies shown
Showing 241-252 of 1,811
Other study type icon
CompletedNCT03115671

Efficacy Study of Vayarin in Children With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD)

Official study title

An Open-label Pilot Study on the Efficacy of Phosphatidylserine-Omega 3 (Vayarin) in Pediatric Patients Diagnosed With Autism and Comorbid Attention Deficit Hyperactivity Disorder (ADHD)

This study has finished and is no longer accepting participants.

In Singapore
ADHDInterventional studyAges 6–12
Countries
Singapore
Sponsor
Institute of Mental Health, Singapore
Other study type icon
CompletedNCT01798381

Essential Fatty Acids in Adult ADHD

Official study title

The Relationship of Essential Fatty Acids to Cognitive, Electrophysiological and Behavioural Function in Adults With Attention Deficit Hyperactivity Disorder and Controls

This study has finished and is no longer accepting participants.

In Homburg/Saar
ADHDPlacebo comparisonAges 18–60
Countries
Germany
Sponsor
Universität des Saarlandes
Other study type icon
CompletedNCT04378517

Evaluating the Feasibility of FAM-SOTC Intervention for Families of Adolescents With ADHD: Study

Official study title

Evaluation of the Feasibility of Family Strength-oriented Therapy Conversation for Families of 13-18 Years Old Adolescents With Attention-Deficit/Hyperactivity Disorder, at the Child and Adolescent Outpatient Unit: A Pilot Study

This study has finished and is no longer accepting participants.

In Reykjavik
ADHDInterventional studyAges 13–17
Countries
Iceland
Sponsor
University of Iceland
Drug study icon
CompletedNCT01107496

Evaluation of Immediate-Release Viloxazine in Adults With ADHD

What is this study about?

Researchers compared IR Viloxazine and placebo, tracking side effects to assess safety and tolerability in adults with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Bradenton
ADHDMedication studyAges 18–64
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT04016779

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

What is this study about?

Researchers compared SPN-812 and placebo, tracking side effects to assess safety in adults with ADHD.

This study has finished and is no longer accepting participants.

Multiple locations, including Garden Grove
ADHDMedication studyAges 18–65
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc. (Pharmaceutical company)
Drug study icon
CompletedNCT02249299

Experimental Medicine in ADHD - Cannabinoids

Official study title

The Effects of Sativex on Neurocognitive and Behavioural Function in Adults With Attention-deficit/Hyperactivity Disorder; The EMA-C Study (Experimental Medicine in ADHD - Cannabinoids)

This study has finished and is no longer accepting participants.

In London
ADHDMedication studyAges 18–55
Countries
United Kingdom
Sponsor
King's College London (University)
Behavioral study icon
TerminatedNCT03638466

Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With ADHD

Official study title

Exploratory Neuroimaging Study to Evaluate the Effect on Brain Activity of SPN-810 for Impulsive Aggression (IA) in Patients With Attention-Deficit/Hyperactivity Disorder (ADHD) in Conjunction With Standard ADHD Treatment

This study ended early.

Multiple locations, including Lakeland
ADHDMedication studyAges 8–12
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc. (Pharmaceutical company)
Other study type icon
Active Not RecruitingNCT06885060

Exploring Eye Vergence Markers ADHD) and ASD

Official study title

Exploring Eye Vergence Markers in Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD).

This study is no longer accepting new participants.

Multiple locations, including Barcelona
ADHDObservational studyAges 6+
Countries
United Kingdom, Spain
Sponsor
Elizabeth Kilbey

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.